0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 121-140 of 196 Articles
Original Investigation |  FREE
Debra A. Butt, MD, MSc, CCFP, FCFP; Muhammad Mamdani, PharmD, MPH; Peter C. Austin, PhD; et al.
Arch Intern Med. 2012;172(22):1739-1744. doi:10.1001/2013.jamainternmed.469.
Includes: Supplemental Content

Original Investigation |  FREE
Kishore M. Gadde, MD; Mariko F. Kopping, MS, RD; H. Ryan Wagner, PhD; et al.
Arch Intern Med. 2012;172(20):1557-1564. doi:10.1001/2013.jamainternmed.99.
Includes: Supplemental Content

Original Investigation |  FREE
Sengwee Toh, ScD; Marsha E. Reichman, PhD; Monika Houstoun, PharmD; et al.
Arch Intern Med. 2012;172(20):1582-1589. doi:10.1001/2013.jamainternmed.34.
Includes: CME, Supplemental Content

Invited Commentary | 
Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(20):1546-1547. doi:10.1001/2013.jamainternmed.293.

Review Article |  FREE
András Komócsi, MD, PhD; András Vorobcsuk, MD, PhD; Dániel Kehl, MS; et al.
Arch Intern Med. 2012;172(20):1537-1545. doi:10.1001/archinternmed.2012.4026.
Includes: Supplemental Content

Original Investigation |  FREE
Daniel M. Witt, PharmD, FCCP, BCPS; Thomas Delate, PhD; David A. Garcia, MD; et al.
Arch Intern Med. 2012;172(19):1484-1491. doi:10.1001/archinternmed.2012.4261.
Includes: Supplemental Content

Invited Commentary | 
Daniel J. Brotman, MD; Amir K. Jaffer, MD
Arch Intern Med. 2012;172(19):1492-1493. doi:10.1001/archinternmed.2012.4309.

Invited Commentary | 
Chee M. Chan, MD, MPH; Andrew F. Shorr, MD, MPH
Arch Intern Med. 2012;172(18):1375-1376. doi:10.1001/archinternmed.2012.3650.

Research Letters |  FREE
Abeer Ahmad, MSc; Giel Nijpels, MD, PhD; Jacqueline M. Dekker, PhD; et al.
Arch Intern Med. 2012;172(17):1346-1347. doi:10.1001/archinternmed.2012.2816.

Original Investigation |  FREE
Gary D. Friedman, MD, MS; Maryam M. Asgari, MD, MPH; E. Margaret Warton, MPH; et al.
Arch Intern Med. 2012;172(16):1246-1251. doi:10.1001/archinternmed.2012.2754.

Special Article | 
Neil A. Holtzman, MD, MPH
Arch Intern Med. 2012;172(15):1174-1177. doi:10.1001/archinternmed.2012.2204.

Commentary | 
Donald M. Marcus, MD; Arthur P. Grollman, MD
Arch Intern Med. 2012;172(13):1035-1036. doi:10.1001/archinternmed.2012.2687.

Original Investigation |  FREE
Iskandar Idris, MD, FRCP, FRCP(Edin); Graham Warren, PhD; Richard Donnelly, MD, PhD
Arch Intern Med. 2012;172(13):1005-1011. doi:10.1001/archinternmed.2012.1938.

Invited Commentary | 
Sonal Singh, MD, MPH; Jodi B. Segal, MD, MPH
Arch Intern Med. 2012;172(13):1011-1013. doi:10.1001/archinternmed.2012.2461.

Research Letters |  FREE
Pieter A. Cohen, MD
Arch Intern Med. 2012;172(13):1038-1039. doi:10.1001/archinternmed.2012.1677.

Original Investigation |  FREE
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
Arch Intern Med. 2012;172(12):930-936. doi:10.1001/archinternmed.2012.1796.

Invited Commentary | 
Douglas C. Bauer, MD
Arch Intern Med. 2012;172(12):936-937. doi:10.1001/archinternmed.2012.1827.

Editor's Correspondence | 
Niki Katsiki, MSc, PhD, MD, FRSPH; Maciej Banach, MD, PhD, FAHA, FESC, FASA, FRSPH
Arch Intern Med. 2012;172(11):895-896. doi:10.1001/archinternmed.2012.1240.

Editor's Correspondence | 
Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.

Editor's Correspondence | 
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1297.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Ophthalmology
Observation  | 
Unexpected Hypotony After Glaucoma Drainage Implant Surgery Associated With Anti–Vascular Endothelial Growth Factor Treatment
Ambika Hoguet, MD; Richard K. Parrish II, MD